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Background: High-throughput methods that ascribe a cellular or physiological function for each gene product are
useful to understand the roles of genes that have not been extensively characterized by molecular or genetic
approaches. One method to infer gene function is "guilt-by-association", in which the expression pattern of a poorly
characterized gene is shown to co-vary with the expression of better-characterized genes. The function of the
poorly characterized gene is inferred from the known function(s) of the well-described genes. For example, genes
co-expressed with transcripts that vary during the cell cycle, development, environmental stresses, and with
oncogenesis have been implicated in those processes.
Findings: While examining the expression characteristics of several poorly characterized genes, we noted that we
could associate each of the genes with a cellular phenotype by correlating individual gene expression changes
with gene set enrichment scores from individual samples. We evaluated the effectiveness of this approach using a
modest sized gene expression data set (expO) and a compendium of gene expression phenotypes (MSigDBv3.0).
We found the transcripts that correlated best with enrichment in mitochondrial and lysosomal gene sets were
mostly related to those processes (89/100 and 44/50, respectively). The reciprocal evaluation, ranking gene sets
according to correlation of enrichment with an individual gene’s expression, also reflected known associations for
prominent genes in the biomedical literature (16/19). In evaluating the model, we also found that 4% of the
genome encodes proteins that are associated with small molecule and small peptide signal transduction gene sets,
implicating a large number of genes in both internal and external environmental sensing.
Conclusions: Our results show that this approach is useful to infer functions of disparate sets of genes. This
method mirrors the biological experimental approaches used by others to associate individual genes with defined
gene expression changes. Moreover, the approach can be used beyond discovering genes related to a cellular
process to discover meaningful expression phenotypes from a compendium that are associated with a given gene.
The effectiveness, versatility, and breadth of this approach make possible its application in a variety of contexts and
with a variety of downstream analyses.
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Background
Groups of genes that are co-expressed in a subset of
samples, sometimes termed gene modules, can reflect an
underlying biological activity. This type of "guilt-by-
association" can be a powerful method to infer a gene's
cellular role. Sets of genes that are co-expressed in varying
cellular states, such as transcripts that are co-expressed
during different phases of the cell cycle, transcripts that
vary upon certain environmental exposures, transcripts
that vary during cellular or tissue differentiation, and tran-
scripts that show conserved coregulation across different
organisms can be especially insightful [1-7].
Many of the current models that describe gene co-
regulation are probabilistic and can be grouped into one
of two general categories: 1) models that associate gene
expression changes with response to a defined experi-
mental or biological condition (such as those described
above) and 2) models that group genes by similarities in
expression patterns across a compendia of gene expres-
sion profiles, often as a genomic-approach. An example
of a model that falls into the first category is the work
described by Hughes et al., in which expression profiles
from yeast that contained targeted deletion of genes with
unknown functions were compared to expression pro-
files from yeast with targeted deletion of genes with
known functions [5]. The functions of these uncharac-
terized genes were subsequently inferred based on simi-
larity to the transcriptional responses of inactivation of
genes with known functions. In the second category,
gene pairs that are co-expressed across a series of ex-
pression profiles are used to infer similarities in bio-
logical functions. Gene networks are often constructed
to relate genes to one another in a pair-wise fashion.
However, the inferred functions of transcriptionally
related genes are not discovered based on similarity to a
defined biological perturbation as described in the first
category of models [8,9]. Together, these guilt-by-
association approaches have been useful to identify func-
tions of transcripts ranging from disease-associated
genes to microRNA function [10,11]. In addition, a
number of other context-specific co-regulation associa-
tions have been proposed [12-17] and several guilt-by-
association models have been extended to incorporate a
wider variety of genomic information with the gene pair
associations, such as location data [18], motif profiles
[19], phenotypic data [20] and GWAS signals [21].
Gene pair associations, networks, and gene modules fit
well with our understanding of the regulation of bio-
logical systems [22]. Although gene modules constructed
from tumor gene expression data have proven to capture
important characteristics of tumors [14,23,24], interpret-
ation of these modules can be difficult if the genes mak-
ing up the modules are not clearly linked to a cellularphenotype. Hence, a disadvantage of guilt-by-association
approaches is that once a gene module is defined, the
biological significance of the module is not immediately
clear. While expert examination and literature curation
of the genes in the module can provide insight into the
biological role of the module, this is inefficient if a large
number of modules are under examination or if a mod-
ule contains a high proportion of genes with unknown
roles. Consequently, gene set enrichment analysis
approaches are used to allow researchers to understand
the gene expression variability observed in their analyses
in terms of pre-defined lists of genes with known bio-
logical or experimental underpinnings, termed gene sets
[25,26]. Gene sets associated with a given biological
process are useful tools to investigate coordinated
changes in cellular processes. Large collections of gene
sets have been made publicly available (e.g., MSigDB,
GO, KEGG) and can be used with gene set enrichment
approaches to find which gene sets best capture the dif-
ference in transcriptional characteristics between various
environmental exposures, disease states, developmental
states, or other experimental comparisons. It is therefore
possible to identify the biological process associated with
a transcriptional profile by comparison to well-defined
gene sets.
To make explicit associations between genes and the
biological processes captured by gene sets, we examined
the correlations between individual fold-change gene ex-
pression values and gene set enrichment statistics in
human tumor tissue samples. We explored the effective-
ness of this guilt-by-association approach by genome-
wide interrogation of individual genes for strongly
correlated gene sets. Specifically, we evaluated the effect-
iveness of finding individual genes that correlate with
pre-defined mitochondrial and lysosomal gene sets and
the more broad utility of this approach to associate
genes with other cellular components and processes. Of
the gene sets examined, those relating to environmental
sensing were associated with the largest fraction of the
genome. We found implementation of this method to be
straightforward and computationally efficient, while
often producing meaningful associations consistent with
the biological literature. Further, we propose that a var-
iety of secondary analyses that incorporate orthogonal
data can be applied to aid in the understanding of bio-
logical networks and gene regulation.
Methods
Overview
One objective of this study was to determine the extent
that the expression of an individual gene was correlated
with one or more gene sets. To perform this association,
first the overall expression characteristics of a gene set,
such as OXPHOS, are collapsed into a summary statistic
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pression of genes within the gene set [25]. Second, this
measure of enrichment is compared with an individual
gene’s fold-change expression value (Figure 1A). Two
types of inputs are required to perform this analysis: 1)
an a priori defined gene set and 2) a gene expression
data set that contains sufficient gene expression variabil-
ity to associate individual genes with the gene set. Data
sets with high variability often allow for an increase in
the signal to noise inherent in the data. We, like others,
noted that large variability in individual gene transcript
levels exists in tumor tissue when compared to non-
diseased cells isolated from the same tissue type. For ex-
ample, a 16-fold range of normalized fold-change ex-
pression values was found for the nuclear encoded
mitochondrial gene NDUFA7 and many other mitochon-
drial subunits in the samples from the Expression Pro-
ject for Oncology data set (expO, Additional file 1:Figure 1 Schematic for comparison of individual gene expression val
expression array data is computed for each tumor sample t (N=1,949) with
4,438 gene sets described in Methods is computed. Comparison of fold-ch
using Spearman correlation. For a given gene, such as the hypothetical exa
Methods for detailed description). B) Enrichment in gene sets is calculated
Volsky (2005). Variables used in Z-score calculation are described in MethodFigure S1). Therefore, we used this tumor tissue-derived
expression data set for our analysis. For the a priori
defined gene sets, we used 4,438 human gene sets
included in the MSigDB.
To implement this approach for a given gene set [27]
and a given tumor sample, the expression levels of the
genes in the gene set were extracted, transformed to
log2-space (fold-change), and an enrichment score was
produced that summarizes the expression levels of those
genes in that particular sample (Figures 1A). The enrich-
ment score in this analysis is the score proposed by Kim
and Volsky [25] (Figure 1B) which comprises the average
expression value of the genes in the set, weighted by the
variability of expression and the number of genes in the
set (Z-score). However, other similarly calculated para-
metric enrichment scores could also be used [28,29]. For
a given gene set, this process was repeated for every
sample in the expression data series to yield sample-wiseues to enrichment in gene sets. A) Relative, log2-transformed gene
tissue-matched controls. For each tumor, enrichment in each of the
ange gene expression values with enrichment scores is conducted
mple NDUFA7, gene sets are sorted by the correlation coefficients (see
using the parametric gene set enrichment approach from Kim and
s.
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an individual gene was then compared to the gene set
enrichment score across all samples using a Spearman
correlation coefficient.
Processing of gene expression datasets
Gene expression data from the human tumor data series
of the Expression Project for Oncology (expO) were
used and are publicly available from the GEO database
(GSE2109). This data series contains gene expression
data sets representing 1949 tumor samples of various
origins and classifications, conducted with Affymetrix
HG-U133 Plus2 arrays. Control samples were chosen
from a compendium of array data for non-diseased
human tissue, also publicly available from the GEO data-
base (GSE3526, N=163) and Affymetrix [30], N=33).
Sample datasets used in the analysis were hand-selected
such that the tumor sample data was paired with tissue-
matched control data for a total of 1949 tumor samples
and 196 controls and only relative log2-transformed
(fold-change) values were used as expression values in
the subsequent analyses (Additional file 2: Table S1).
The data analyses were performed in the R statistical en-
vironment v2.11.11 [31,32] with software available from
the BioConductor Project (version 2.5). Robust Multi-
chip Average (RMA) preprocessing was used for back-
ground adjustment, normalization, and summarization
of raw expression image intensities, as implemented in
the Affy package (1.24.2) with updated probeset map-
pings [33,34].
Gene set enrichment analysis
Parametric gene set enrichment scores (Z-scores) were
computed as implemented in the PGSEA package (ver-
sion 1.20.1) [25] following standardization of each gene
expression value to the median expression value of that
gene in tissue-matched controls. Using the formula from
Kim and Volsky (2005), the Z score was calculated as Z =
(Sm-μ) * m
1/2 / δ, where μ is the mean of fold-change
gene expression values from an individual sample data
set, δ is the standard deviation of the fold-change values
from the individual sample data set, Sm is the mean of
fold-change values for gene set members in that data set,
and m is the size of the gene set (Figure 1B). Gene sets
were obtained from the Molecular Signatures Database
[35] (MSigDB v.3.0 [27], curated from online pathway
databases, biomedical literature, positional information,
and microarray studies). Gene sets with fewer than 22 or
greater than 800 genes were removed to limit biases due
to very small and very large gene sets.
Correlation analysis
Using the preprocessed and standardized expO gene ex-
pression data and the matrix of enrichment scoresderived from that data (gene sets listed as rows and sam-
ples as columns), Spearman correlation was conducted
for all combinations of genes measured on the array and
gene sets that were used to compute the enrichment
scores. This produced an 81 million-element matrix of
rho correlation coefficients through the comparison of
18,185 genes and 4,438 gene set enrichment scores (see
Additional file 3: Table S2). A correlation statistic was
thus found for each possible pair of fold-change expres-
sion values and enrichment scores across all tumor sam-
ples. To calculate a “relative rank”, the distribution of
these correlation statistics was translated to have a mean
of 0 and the transformed correlation statistics were
ranked in magnitude. In this manner, a strong correl-
ation corresponded to a low relative rank and gene sets
associated with each gene were filtered according to the
relative ranking. When examining individual gene sets
for co-regulated genes, enrichment scores were com-
puted after removing each gene from the gene set. This
step was necessary in order to eliminate the possibility
of autocorrelation between a gene, G, that is a constitu-
ent of gene set S that might produce an enrichment
score heavily influenced by that gene.Ranking and filtering results (and relative rank
calculation)
To find genes that were associated with a given gene
set, genes were ranked by rho correlation coefficients to
produce an ordered list of genes whose expression was
correlated with the enrichment scores of the gene set
across the tumor samples. To find gene sets that were
associated with a given gene, a similar process was
used. Importantly, gene sets that were directional down
(e.g., GENESET_EXAMPLE_DN) were grouped as the
opposite correlation sign for consistency in interpret-
ation. To gain a measure of confidence in the associa-
tions observed compared to the distribution of all
possible associations in the data set, we calculated a
relative rank for each gene-by-gene set association. The
relative rank was computed using the rank of the cor-
relation coefficient for the gene with each gene set
compared to the distribution of all possible correlation
coefficients (Additional file 1: Figure S2). The lists of
gene sets associated with each gene were thus sorted by
the relative ranks. Further, gene sets such as certain
cancer “modules” were left out of the rankings if they
were not clearly interpretable [14,36]. Not all genes
described in the book Genome were examined nor were
all of the chromosomes represented. 5SRNA genes were
described for chromosome 1 and NROB1 for the X
chromosome, but were not measured on the array.
Genes were also not explicitly provided for chromo-
somes 2, 21, and 22.
Figure 2 Correlation of a fold-change gene expression value
with a gene set-derived enrichment statistic can elucidate the
function of poorly characterized gene products. A) Plot of fold-
change gene expression values for the gene STYXL1 versus the
enrichment statistics calculated using the WONG_MITOCHONDRIA
gene set. Data points are derived from individual samples within the
expO data series (see Methods). B) Plot of the fold-change
expression values for DUSP6 versus enrichment statistics derived
from the gene set ST_ERK1_ERK2_MAPK_PATHWAY. C) Heatmap of
correlation statistics for the five gene sets that were most strongly
associated with STYXL1 or DUSP6, as determined from all gene sets
examined (N=4,438). The dendrogram on the left represents the
overlap between the gene sets. The dendrogram was generated
using dissimilarities between gene set compositions as previously
described [73].
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To further test whether genes whose expression was
found to be correlated with enrichment in the REAC-
TOME_OLFACTORY_SIGNALING_PATHWAY and the
SHEN_SMARCA2_TARGETS_DN gene sets were related
to olfactory signaling and environmental sensing, we com-
puted and ranked posterior probabilities for enrichment in
GO terms. The posterior probabilities were calculated after
controlling for multiple testing and using all GO categories
with greater than five members, as implemented in the
MGSA package [37]. Gene sets with posterior probabilities
greater than 0.50 were regarded as active, as suggested by
Bauer et al. (2011).
Results
The approach is demonstrated using the STYXL1 gene.
Following a siRNA screen, several genes were identified
that enhanced or diminished the sensitivity of cells to
chemotherapeutics [38]. One of these genes, STYXL1,
was a prominent hit in the siRNA screen but the cellular
function of this gene was largely unknown. STYXL1
shows homology to protein phosphatases but lacks a
critical cysteine residue that is deemed essential for cata-
lytic activity [39,40]. To identify potential molecular
functions of STYXL1, the expression of STYXL1 was
compared with gene set enrichment scores derived from
all possible gene sets to discover which gene sets were
most closely associated with STYXL1. Statistical meth-
ods that compute significance values corrected for mul-
tiple testing are difficult to apply to this analysis due to
the large number of overlapping, non-independent gene
sets that violate assumptions of independence. Rather
than account for the overlap when determining the con-
fidence [41], we noticed that the population of rho coef-
ficients were symmetrically distributed with a mean of
−0.0262 and a standard deviation of 0.261 (Additional
file 1: Figure S2). We leveraged this finding to approxi-
mate our confidence in the gene-gene set associations
with relative ranks of individual gene-pathway rho coef-
ficients (both positive and negative) by first centering
the distribution on zero and then ranking the absolute
values of individual gene-pathway rho coefficients. The
gene set that correlated most strongly with STYXL1
transcript levels was known to be mitochondrial-related,
WONG_MITOCHONDRIA (Additional file 3: Table S2,
Figure 2A). The association of STYXL1 with the gene set
WONG_MITOCHONDRIA had a correlation coefficient
equal to 0.59 that ranked 879,685th of the 80,705,030
coefficients calculated. This produced a relative rank of
0.011, indicating the rho correlation coefficient obtained
from this gene-gene set pair was in the top 1.1% of all
gene-gene set pairs examined. Further, among the com-
pendium of gene sets tested, several of the strongest cor-
relations with STYXL1 transcript expression weremitochondrial gene sets (Figure 2C). In support of this
association, STYXL1 was shown to be a previously
uncharacterized mitochondrial protein [42]. We also
examined potential roles of DUSP6, a protein phosphat-
ase that shows high homology with STYXL1 but con-
tains the cysteine residue required for catalytic activity.
In contrast to STYXL1, DUSP6 was most strongly corre-
lated with phosphatase-related gene sets, such as
ST_ERK1_ERK2_MAPK (Figure 2B and C). The associ-
ation of DUSP6 with the ST_ERK1_ERK2_MAPK gene
set was assigned a relative rank of 0.004, indicating that
this gene-gene set pair were in the top 0.4% of all gene-
gene set pairings.
To determine if similar gene set associations were evi-
dent for STYXL1 and DUSP6 using gene-network model
approaches, we input the STYXL1 and DUSP6 gene
names into the online tools GeneMANIA [43] and
COXPRESdb [44]. The GeneMANIA tool uses available
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dictions, pathways, co-localization, shared protein
domains, and genetic interactions to create a network of
genes related to the gene(s) input into the model [45]
while the COXPRESdb tool uses coexpression of genes
across seven animal species to build gene networks [46].
We noted that explicit pathway associations were not
available for STYXL1 using these tools. Thus, to deter-
mine pathway associations for these two genes, we
extracted the 20 most significantly associated genes
using each tool and compared them to the same com-
pendium of gene sets described above, ranking according
to significance with a hypergeometric distribution. Using
GeneMANIA, the gene sets most related to STYXL1
were KEGG_PEROXISOME (p=0.003) and RICKMAN_
METASTASIS_UP (p=0.004). In contrast to the frequent
mitochondrial gene set associations (18 of the top 20
correlating gene sets) when using the gene expression
and enrichment score correlations (Figure 2A and 2C),
only one mitochondrial gene set appeared in the 20 most
strongly associated gene sets using this gene-network
model. When using COXPRESdb, the gene sets most
related to STYXL1 were found to be chr7q22 (p<0.001)
and MORF_XPC (p<0.001). Three mitochondrial gene
sets were evident in the 20 most-significantly associated
gene sets with this model. Both of the models showed a
variety of gene sets related to DUSP6- primarily MAPK
signaling, growth factor signaling, and phosphorylation
activity.
Proteins located within the mitochondria play an im-
portant role in cellular metabolism through the process
of oxidative phosphorylation (OXPHOS). OXPHOS is
accomplished by a series of protein complexes within
the mitochondria known as complexes I, II, III, IV, and
V, encoded by approximately 100 genes. Several reports
show that genes whose protein products are located in
the mitochondria tend to be transcriptionally co-
regulated [5,9,47-49]. Therefore, to test whether this
gene – gene set association existed for genes encoding
complexes I-V, we calculated enrichment in the expres-
sion of known nuclear-encoded OXPHOS related genes,
given by the MOOTHA_VOXPHOS gene set [49], and
compared the enrichment scores to fold-change gene ex-
pression values for individual genes encoding complexes
I-V. We found enrichment values obtained using the
MOOTHA_VOXPHOS gene set were correlated with
the expression of individual OXPHOS mitochondrial
subunit genes in the samples of the expO tumor dataset.
Ninety percent (72/80) of the OXPHOS mitochondrial
subunit genes were correlated with enrichment in the
MOOTHA_VOXPHOS gene set with a relative rank of
less than 0.05 (corresponding to a rho of greater than
0.50, Additional file 1: Figure S3). Though known
OXPHOS mitochondrial subunit genes correlated withthe MOOTHA_VOXPHOS gene set, we also determined
which genes showed the strongest correlations with the
MOOTHA_VOXPHOS gene set. Upon examining the
100 genes with the largest rho correlation coefficients,
we found that 81 were known to be either OXPHOS
mitochondrial subunit genes or in the mitochondrial
protein compendium, Mitocarta (Figure 3A). Note that
the total number of Mitocarta genes (N=1010) is less
than the total number of genes in the database (N=1098)
because not all of the Mitocarta genes were represented
in the gene expression array data. Nineteen of the genes
whose expression was strongly correlated with the
OXPHOS gene set were not in Mitocarta, indicating that
there is not current evidence showing strong mitochon-
drial localization of their protein products. However,
eight of these genes have GO annotations relating to
mitochondria or metabolism, suggesting they may be
functionally related to OXPHOS (Figure 3B).
In addition, we compared the 100 genes with the high-
est rho correlation coefficients using our method to the
scores generated by Baughman et al. [48] who calculated
the probability that a gene is co-expressed with the
OXPHOS gene set (Figure 3C). The method proposed
by Baughman et al. requires the curation and download-
ing of 1,427 individual human and mouse gene expres-
sion datasets, the preprocessing of each data set,
calculation of correlation within each dataset, and com-
bination of the resulting correlations to build a weighted
summary score. The result of this activity is a single
gene-gene set pair score. Our approach is comparatively
simple, using only the human expO microarray data set
and tissue-matched normal data. The initial findings
from our approach were qualitatively similar to those
obtained using the computationally intensive approach
of Baughman et al. The top 100 genes we found strongly
correlated with the MOOTHA_VOXPHOS gene set
were also ranked highly in the Baughman et al. list of
OXPHOS probability scores for each gene. Conversely,
comparison of the top 100 genes identified in the
Baughman et al. list showed high rankings within our
ranked list of all genes in the datasets (Additional file 1:
Figure S4).
In order to test this model beyond mitochondria, we
assessed the co-regulation of individual lysosomal genes
with enrichment in the lysosome gene set, KEGG_LY-
SOSOME. Lysosomal genes also show a high degree
of transcriptional co-regulation in tissue culture cells
(Sardiello et al 2009). The 50 genes that correlated
strongest with this gene set were identified and compared
with genes that were either identified as being lysosomal
via a proteomic survey or associated with lysosomal GO
annotation (Accession GO:0005764) [50]. Fifty percent
(25/50) of genes identified encode for lysosome-associated
proteins (Additional file 1: Figure S5A). Of the twenty-five
Figure 3 Genes that associate most strongly with the OXPHOS expression phenotype are mitochondria-associated. A) The 100 most
strongly correlated genes with the MOOTHA_VOXPHOS gene set (OXPHOS gene set correlations) as compared to known electron transport
subunit genes (OXPHOS genes, see Main Text) and mitochondrial-associated genes from the Mitocarta compendium. Genes were filtered to only
include those that were interrogated in the gene expression array data. Nineteen genes associated with MOOTHA_VOXPHOS were not associated
with Mitocarta or known mitochondrial subunit genes. B) The Gene Ontology classifications of the 19 OXPHOS gene set correlation genes
described in A. C) Rank plot showing the top 100 OXPHOS-correlated genes described in A versus the predictions made by Baughman et al. [48].
Also shown are the GO associations of 10 of the 100 OXPHOS-correlated genes that were ranked lower by Baughman et al (a-j).
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that were not in the proteomic survey or identified with
the lysosomal GO annotation, 19 (76%) possessed GO
terms related to the endoplasmic reticulum, golgi, or
vacuoles (Additional file 1: Figure S5B). Therefore, 88%
(44/50) of genes associated with the KEGG_LYSOME
gene set were related to vesicle transport.
To examine the effectiveness of this method for insight
into protein functions more broadly, we examined a set
of genes with widely recognized biomedical significance,
described in the popular biomedical science book Gen-
ome, by Matt Ridley [51]. In this book, Ridley describes
a set of well-studied genes that lie on different chromo-
somes. For each of these genes, we found the highest
ranked gene set representative of its role based on cur-
ation of the literature. Note that this was not meant to
represent an exhaustive summary of the literature but
instead a sample of studies or reviews suggesting the
identified relationships. Of the 14 well-studied genes
described, representative gene sets were found withinthe top five ranked correlations for 12 of the genes
(Figure 4A). In all cases (14 of 14), the relative ranks for
the correlations were in the top 10% of all correlation
coefficients (i.e. less than 0.10). Expression of the breast
cancer susceptibility gene, BRCA2, was most strongly
correlated with gene sets representing cell cycle check-
points and DNA damage response (Figure 4A and
Additional file 3: Table S2). These gene sets are consistent
with the role for BRCA2 in DNA repair and cell cycle
checkpoints that has been well established in the litera-
ture. Expression of the apoprotein gene APOE correlated
with gene sets related to hydrolase and peptidase activity
as well as lipid metabolism. These gene sets are also con-
sistent with the known role of APOE as a mediator of nor-
mal lipid and amino acid metabolism [52,53]. FOXP2 is a
gene encoding a transcription factor that is strongly
tied to an autosomal dominant speech and language
neurological disorder [54]. A binding partner to
FOXP2, FOXP1, has recently been found confined to
projection neurons [55]. Though the specific function
Figure 4 (See legend on next page.)
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Figure 4 Enrichment scores of gene sets are related to the gene’s known biological role. A) The ranks of the strongest-correlated gene
sets with similar characteristics to the known biological roles of genes highlighted in the book Genome. References are listed below. B) Plot of the
HTT gene expression profile across all samples (green line, running median window size=11) compared to the median-centered fold-change
expression for all genes of the most strongly correlated gene set, GCM_LTK (black lines: Q1= first quartile, Q3 = third quartile, heatmap: N=41). C)
Plot of the ABO gene expression profile across all samples (orange line, running median window size=11), compared to the median-centered
fold-change expression for all genes of the most strongly correlated gene set, VOLTAGE_GATED_CHANNEL_ACTIVITY (black lines: Q1= first
quartile, Q3= third quartile, heatmap: N= 72). D) Genes from the book Genome with poorly- or broadly-characterized roles and the top five
ranking gene sets by correlation coefficients for each gene are listed. In A and D, gene sets were listed according to their relative ranking (i.e.
distance from the mean of the null distribution) and “DN” gene sets with negative correlations are shown in italics. Uninformative cancer gene
modules were not included. References for part A: [79]a, [80]b, [81]c, [82]d, [83]e, [84]f, [85]g, [86]h, [87]I, [88]j, [89]k, [90]l, [91]m, [92]n, [93]o, [94]p,
[95]q, [96]r, [97]s, [98]t, [99]u, [52]v, [100]w.
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of FOXP2 corresponded best with enrichment in a gene
set related to neurotransmitter release, CALCIUM_
CHANNEL_ACTIVITY. Other highly correlated gene sets
included additional neuron-related gene sets as well as
gene neighborhoods, consistent with its role as a tran-
scription factor (Additional file 3: Table S2).
Five genes shown in the list- HTT, L1TD1, ABO,
HOXC4, and PRNP, have poorly defined or ambiguous
biological roles. To determine whether these genes asso-
ciate strongly with any gene sets, we examined the top
ranked gene sets (Figure 4B-D). For the huntingtin gene,
HTT, an association was found with the brain specific kin-
ase LTK (Figure 4B and 4D). This association does not ap-
pear to be driven by a single gene since most of the genes
of the LTK gene set show a similar trend in expression as
HTT across the tumor samples (Figure 4D). Though there
is evidence that LTK has a role in apoptosis [56], add-
itional gene sets appear to be related to immune function
and development pathways for which there is also evi-
dence HTT is involved [57-59]. Expression of the gene
ABO was strongly correlated with several gene sets related
to the activity of transmembrane channels, indicating a
potential role of this gene (Figure 4C and 4D). For three
genes, L1TD1, HOXC4, and PRNP, a single biological role
is not apparent in this analysis. In summary, in 16 of 19
(84%) cases, the predictions generated by the integration
of fold-change gene expression and gene set enrichment
scores were associated with consistent biological processes
(Additional file 3: Table S2).
While examining the gene set associations for these and
other genes, we noticed that some gene sets seemed to be
more frequently associated with genes than others. To de-
termine which gene sets were related to the largest reper-
toire of genes, we examined the five strongest correlating
gene sets for every well-measured gene in the expression
dataset. The largest number of genes was correlated with
enrichment in gene sets related to chemo-sensing (amino
acid and small odorant receptors) and transmembrane
channel signaling (Figure 5A). Specifically, a gene set
composed of potential odorant receptors, REACTOME_OLFACTORY_SIGNALING_PATHWAY, was correlated
with over 4% of the genes in the dataset. Olfactory recep-
tors are G-protein coupled receptors expressed in the
main olfactory epithelia and other tissues that bind small,
volatile 'odorous' molecules [60,61]. The olfactory gene
family is the largest family of genes with more than a
thousand genes encoding potential odorant receptors in
humans [60,62]. However, of the 1,182 genes we found co-
regulated with genes of the REACTOME_OLFACTORY_
SIGNALING_PATHWAY, only 47 were constituent genes
of the gene set (4%), suggestive that additional genes may
play a role in this process.
The olfactory receptor protein family consists of
mainly seven-transmembrane receptors that are linked
to ion flux through the cAMP-signaling pathway. Bind-
ing of small molecules to the receptor induces a signal-
ing cascade whereby the activated receptor activates a
G-protein, leading to the production of adenylyl cyclase.
Subsequently, adenylyl cyclase binds to a cyclic-
nucleotide-gated-ion channel, inducing channel opening
and depolarization of the cell membrane. To determine
whether the genes co-regulated with the REACTOME_
OLFACTORY_SIGNALING_PATHWAY gene set were
involved in the olfactory signaling process, we placed the
genes with GO annotations into groups based on those
annotations (Figure 5B). Consistent with this signaling
cascade, the genes that were not members of the gene set
could be classified predominantly to membrane signaling
with activities related to GPCR activity, ion transport,
ATP-binding, and signal transduction. Interestingly,
many of the genes associated with the REACTOME_
OLFACTORY_SIGNALING_PATHWAY gene set were
uncharacterized proteins or open reading frames
(196/1182 16.6%). The association with this number of
uncharacterized proteins is nearly double what would be
expected by chance (p<0.00001).
The second most prevalent gene set association
involved SHEN_SMARCA2_TARGETS_DN related
genes (Figure 5A). Although the two gene sets SHEN_
SMARCA2_TARGETS_DN and REACTOME_OLFACTORY_
SIGNALING_PATHWAY had little overlap (N=74, N=327,
Figure 5 Environment sensing gene sets are associated with the largest numbers of genes. A) Histogram of the number of gene sets
associated with a given number of genes. The frequency of the gene set was based on how often the gene set appeared in the top five
correlated gene sets for each gene. The Y-axis is log10-transformed. Inset is a Venn diagram showing the degree of overlap between the genes
associated with the gene sets REACTOME_OLFACTORY_SIGNALING_PATHWAY and SHEN_SMARCA2_TARGETS_DN. B) Histogram showing the 10
most frequently represented GO pathways for genes associated with, but not members of, the gene sets
REACTOME_OLFACTORY_SIGNALING_PATHWAY (dark colored bars) and SHEN_SMARCA2_TARGETS_DN (light colored bars). In bold are GO terms
most closely related to environmental sensing. GO annotations are grouped into categories: cellular component (green), molecular function (red),
and biological process (blue). Frequencies are based on the number of genes with a specific GO annotation versus the total number with GO
Annotations (totals for REACTOME_OLFACTORY_SIGNALING_PATHWAY: CC, N=734; MF, N=642; BP, N=607; totals for
SHEN_SMARCA2_TARGETS_DN: CC, N=705; MF, N=637; BP, N=596). Significant enrichment in GO categories was found for the olfactory* and
Smarca2+ associated genes using the model-based gene set analysis (MGSA) approach, as described in the Methods.
Klomp and Furge BMC Research Notes 2012, 5:370 Page 10 of 15
http://www.biomedcentral.com/1756-0500/5/370respectively; overlap=3 genes), the genes whose expression
was correlated with enrichment in these gene sets were
somewhat redundant (Venn diagram, Figures 3 and 4A).
SMARCA2 is a component of the large SWI/SNF
ATP-dependent chromatin-remodeling complex required
for transcriptional activation of genes repressed by chroma-
tin. Similar to the olfactory signaling gene set, of the
1,130 genes whose expression correlated best with
SHEN_SMARCA2_TARGETS_DN, only 99 genes were
constituent members of the gene set (9%). Also, like the ol-
factory signaling gene set, the associated non-constituent
genes could be primarily classified to membrane signaling,
GPCR activities, ion transport, ATP-binding, and signaltransduction GO and PFAM annotations (Figure 5B).
As with the REACTOME_OLFACTORY_SIGNALING_
PATHWAY, more of the genes associated with SHEN_
SMARCA2_TARGETS_DN coded for uncharacterized
proteins than would be expected by chance (162/1130,
14.3%, p<0.00001).
We examined the genomic positions of the genes asso-
ciated with these two gene sets to determine if shared
cis-regulatory elements might exist between the correlated
genes and the constituent genes of the gene sets. However,
neither the genes co-regulated with REACTOME_
OLFACTORY_SIGNALING_PATHWAY nor the genes
co-regulated with SHEN_SMARCA2_TARGETS_DN were
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spective gene sets (p=0.49 and p=0.66, respectively). The
SHEN_SMARCA2_TARGETS_DN gene set was con-
structed by examining genes that correlated inversely with
SMARCA2 expression in prostate cancer samples [63].
The association of this gene set with olfactory signaling
indicates a potential link between chromatin remodeling
and the expression of chemo-sensing genes as recently
described by Magklara et al. [64].
Discussion
We showed that correlation of fold-change gene expres-
sion values and gene set enrichment scores is an effect-
ive method of inferring cellular roles of genes. Using this
correlation procedure has allowed us to confirm known
roles for well-characterized genes by ranking the correla-
tions of the gene expression with a compendium of gene
sets. The approach described is computationally efficient
and simple to implement and we demonstrated that its
ability to identify mitochondria-related genes is as effect-
ive as approaches recently devised by Baughman et al.
[48]. Notably, the association matrix took approximately
57 hours of computational time to generate using a
2.2GHz (8-cores) processor with 9.6 Gb of RAM. There-
fore, this type of association matrix can be computed
from a variety of gene expression datasets using a variety
of gene sets. Likewise, we have also implicated a mito-
chondrial role for several genes not currently known to
be associated with mitochondria through the “guilt-by-
association” paradigm. Following this paradigm, we
found that a variety of individual genes were associated
with gene sets functionally related to the known roles of
those genes and that genes with unknown roles tended
to be associated with gene sets that represent biological
themes. We have generated a catalog of co-regulated
gene sets (CGs) that includes all 18,185 genes in the
dataset (Additional file 3: Table S2). This has the poten-
tial to inform a variety of high throughput genomic
approaches.
Although olfactory receptors are in a large family of
G-protein coupled receptors (GPCRs), the association of
many other genes with the REACTOME_OLFACTORY_
SIGNALING_PATHWAY gene set was somewhat sur-
prising. Olfactory receptors are commonly associated
with environmental sensing, including the perception of
tastes, odors, and chemical moieties through specialized
sensory receptor cells in the nose, mouth, tongue, and
skin. Information about a stimulus is transduced
through a cascade of molecular and cellular events into
electrical signals that are recognized by the nervous sys-
tem. However, recent reports indicate that olfactory
receptors may play a much more diverse role in chemo-
sensing [65-68]. Epithelial cells along the entire
gastrointestinal tract are involved in chemosensing andproposed nutrient absorption [68]. Outside of the
gastrointestinal epithelium, olfactory receptors have
been found to play important roles in myogenesis, and
at least one receptor, MOR32, could direct myocyte
migration through a yet to be identified soluble chemo-
attractant secreted by fusing muscle cultures [69]. Mul-
tiple studies also indicate the importance of olfactory
receptors in sperm cell chemotaxis [70,71]. Perhaps
most interestingly, an olfactory receptor over-expressed
in prostate cancer, OR51E2, interacts with androstenone
derivatives and this interaction regulates cell prolifera-
tion [72]. These findings suggest that chemosensing
mechanisms operate in diverse cell types. Our results
support this possibility and implicate a significant frac-
tion of the coding genome in support of this type of sig-
nal transduction cascade. Several somatic mutations that
have been identified in cancer cells are associated with
olfactory signal transduction using the method put forth
in this report (Additional file 3: Table S2). Whether
these mutations lead to disrupted signal transduction
important to tumorigenesis or proliferation of cancer
cells remains to be explored.
As with all computationally-derived guilt-by-associ-
ation correlations, we also point out limitations to this
type of analysis which include 1) the trends may be
dependent on the expression data used, 2) the analysis
may be affected by low quality gene sets or gene sets
with ambiguous biological underpinnings, and 3) the en-
richment statistic can be influenced by expression of a
gene if it resides within the actual gene set (i.e. self-
fulfilling associations). However, in the latter case the
calculation used for the enrichment statistic should at
least partially compensate for this effect. Though we
used tissue-matched normal tissues to standardize the
tumor tissues in our analysis, we also conducted similar
analyses using only normal tissues and using only tumor
tissues. Many of the gene expression-by-gene set enrich-
ment correlations were similar to our initial findings
when we used these smaller, median-standardized sub-
sets of expression data. However, there tended to be less
expression variability for a given gene across the
restricted data sets and genes with low expression
variability tended to produce incorrect gene set asso-
ciations. We also noted this effect when using a smal-
ler set of tumor-normal gene expression data as
described in [73]. Perhaps intuitively, a sample set with
sufficient expression variability in the gene of interest
should be used. Two obvious sources of expression
variability may come from using a greater number of
samples or increasing the heterogeneity of the tissue
types used.
The general effectiveness of computationally-derived
guilt-by-association approaches is difficult to evaluate.
Without detailed in vitro and in vivo experimental
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idation of an association must be supported by a large
body of literature explicitly detailing both their molecu-
lar functions and biological roles. Some of the best-
studied genes are those with strong links to human
health and disease, as described in the book Genome.
Though we examined these genes with our guilt-by-
association model, it is possible that biomedically prom-
inent genes are biased for their pleiotropic effects and
the model might be less effective for genes with more
subtle roles. Further, interpretation of the literature can
be subjective, especially with the burgeoning numbers of
publications and bias in not publishing “negative” data.
In spite of these challenges, guilt-by-association models
have served to inform a variety of hypotheses over the
past two decades and have been extended in this report
with the generation of sample-wise enrichment scores.
In addition to guilt-by-association, the generation of
sample-wise enrichment scores for numerous, diverse
gene sets lays the foundation for analyses similar to
those recently devised for gene expression array data.
Data mining approaches that are commonly used for
gene expression analysis (clustering approaches [74], dis-
criminate analysis [75], and outlier analysis [76]) can be
applied at the level of pathways/gene sets and can be
integrated with other types of orthogonal data sets such
as genotype information (e.g. “ping-pong” analysis [77]).
We have used a variation of outlier profile analysis
(meta-COPA [78]) to identify tumor samples in this
dataset that contained a gene signature indicative of acti-
vation of the NRF2 transcription factor. The identifica-
tion of subsets of samples that share a similar biological
activity, such as NRF2 activity, can assist in the identifi-
cation of disease subgroups that may not be well
described or may respond differently to treatments. Sev-
eral other gene set enrichment approaches require that
the samples of interest be partitioned into a priori
defined groups for the application of the enrichment
analysis. Unless a signal transduction transcriptional
phenotype is stronger than other transcriptional effects
related to the a prior group assignments (such as tissue
type or proliferation rate), more subtle pathophysio-
logical transcriptional effects can be overwhelmed
and consequently overlooked with those traditional
approaches.
Conclusions
We have outlined a computational approach that has
proven useful to predict gene function using transcrip-
tional data. The approach we describe was successfully
used to identify molecular functions of genes that were
previously not well characterized [42,73]. We found that
gene transcripts that correlated best with enrichment in
mitochondrial and lysosomal gene sets often possessedmitochondrial and lysosomal roles as evidenced in the
literature. Furthermore, gene sets reflective of a gene’s
known cellular role were more strongly correlated with
the gene’s expression than unrelated gene sets. Using
this method, we noted the high number of genes whose
transcripts correlated strongly with enrichment in gene
sets representing small molecule and small peptide sig-
nal transduction. Our results show that this approach is
useful to infer functions of disparate sets of genes with
prominent roles in the biomedical literature and may
complement current methods in situations where other
databases are unable to provide predictions of gene
functions. Further, the effectiveness, versatility, and
breadth of this approach make possible its application
across a variety of contexts and with a variety of down-
stream analyses.
Availability and requirements
Project name: Genome-wide matching of genes to cel-
lular roles using guilt-by-association models derived
from single sample analysis
Project home page: NA
Operating system(s): platform independent
Programming language: NA
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License: NA
Any restrictions to use by non-academics: NA
Availability of supporting data
All data is from publicly available sources (refer to
Additional file 2: Table S1).
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Additional file 1: Figure S1. High gene expression variability exists for
nuclear encoded mitochondrial complex genes in the expO tumor data
set. A) Log2-transformed expression of the mitochondrial gene NDUFA7
in 1949 samples of the expO data set with summarization whisker plot. B)
Summarization whisker plots for all nuclear encoded mitochondrial
complex genes measured on the gene expression array, sorted by
median fold-change expression in tumors relative to normal samples.
Figure S2. Distribution of rho correlation statistics for all gene
expression-by-gene set enrichment pair-wise comparisons (N=8.07x107).
Figure S3. Genes encoding mitochondrial complex genes are correlated
with enrichment in an OXPHOS gene set. Nuclear encoded mitochondrial
complex genes (N=80) are sorted by their rho correlation coefficients
calculated by comparing with enrichment in the MOOTHA_VOXPHOS
gene set across tumor samples of the expO data set. Figure S4. Genes
predicted to be strongly associated with OXPHOS using the method by
Baughman et al. (2009) are also ranked highly in the list of genes
correlated with the MOOTHA_VOXPHOS gene set. Rank plot showing a
comparison of the top 100 genes predicted to be associated with
OXPHOS by Baughman et al. (2009) compared to the rank of the genes
using our method. The 10 most poorly ranked genes are listed as a-j with
indication of whether they possess a mitochondria or metabolism related
GO association. Figure S5. A lysosome gene expression phenotype is
associated with changes in the expression of constituent genes and
genes with known roles in lysosomes and related processes. A) Venn
diagram showing 50 genes that correlate most strongly with the
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http://www.biomedcentral.com/1756-0500/5/370KEGG_LYSOSOME gene set compared to known lysosomal genes
(associated with the GO term “Lysosome” as well as those identified in
Lubke et al. (2009)). B) Listing of the 50 genes that correlated best with
the lysosome gene set from A. In the first column are known lysosomal
genes, in the second column are genes not known to be associated with
lysosomes, and the third column lists examples of GO terms associated
with the non-lysosomal genes.
Additional file 2: Table S1. List of gene expression data set accession
numbers for data used in the analyses.
Additional file 3: Table S2. Catalog of Co-regulated Gene sets (CGs).
Table showing top 10 positive and top 5 negative associated gene sets
for all genes measured on the arrays. Note, gene sets were sorted by
relative ranks for each gene and “DN” directional gene sets were
grouped with the opposite of their rho correlation coefficients (see
Methods).
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